How to buy Aspira Womens Health stock - 19 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Aspira Womens Health stock

Own Aspira Womens Health stock in just a few minutes.

Aspira Women's Health Inc is a diagnostics & research business based in the US. Aspira Womens Health shares (AWH) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in Aspira Womens Health

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Aspira Womens Health. Find the stock by name or ticker symbol: AWH. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Aspira Womens Health reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Aspira Womens Health, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Aspira Womens Health. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Aspira Womens Health share price

Use our graph to track the performance of AWH stocks over time.

Aspira Womens Health shares at a glance

Information last updated 2021-04-15.
52-week rangeUSD$1.05 - USD$10.54
50-day moving average USD$6.98
200-day moving average USD$5.82
Wall St. target priceUSD$12.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$2.93

Buy Aspira Womens Health shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Aspira Womens Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aspira Womens Health financials

Revenue TTM USD$4.7 million
Gross profit TTM USD$1.2 million
Return on assets TTM -67.23%
Return on equity TTM -194.02%
Profit margin 0%
Book value N/A
Market capitalisation USD$715 million

TTM: trailing 12 months

Shorting Aspira Womens Health shares

There are currently 11.9 million Aspira Womens Health shares held short by investors – that's known as Aspira Womens Health's "short interest". This figure is 9% up from 10.9 million last month.

There are a few different ways that this level of interest in shorting Aspira Womens Health shares can be evaluated.

Aspira Womens Health's "short interest ratio" (SIR)

Aspira Womens Health's "short interest ratio" (SIR) is the quantity of Aspira Womens Health shares currently shorted divided by the average quantity of Aspira Womens Health shares traded daily (recently around 914633.33333333). Aspira Womens Health's SIR currently stands at 12.99. In other words for every 100,000 Aspira Womens Health shares traded daily on the market, roughly 12990 shares are currently held short.

However Aspira Womens Health's short interest can also be evaluated against the total number of Aspira Womens Health shares, or, against the total number of tradable Aspira Womens Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aspira Womens Health's short interest could be expressed as 0.11% of the outstanding shares (for every 100,000 Aspira Womens Health shares in existence, roughly 110 shares are currently held short) or 0.1866% of the tradable shares (for every 100,000 tradable Aspira Womens Health shares, roughly 187 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Aspira Womens Health.

Find out more about how you can short Aspira Womens Health stock.

Aspira Womens Health share dividends

We're not expecting Aspira Womens Health to pay a dividend over the next 12 months.

Have Aspira Womens Health's shares ever split?

Aspira Womens Health's shares were split on a 1:10 basis on 3 March 2008. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aspira Womens Health shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Aspira Womens Health shares which in turn could have impacted Aspira Womens Health's share price.

Aspira Womens Health share price volatility

Over the last 12 months, Aspira Womens Health's shares have ranged in value from as little as $1.05 up to $10.54. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aspira Womens Health's is 3.2796. This would suggest that Aspira Womens Health's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Aspira Womens Health overview

Aspira Women's Health Inc. , together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. It provides OVA1, Overa, and Ova1PLUS to detect the risk of ovarian malignancy. The company also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, it owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, the company is developing diagnostic algorithms; and a high-risk screening algorithm for patients who are genetically predisposed to ovarian cancer. It has entered into a collaborative research agreement with Baylor Genetics to co-develop a novel ovarian cancer early-detection test; and an agreement with Dana Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site